nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—OPRM1—alcohol dependence	0.448	1	CbGaD
Alfentanil—OPRM1—Naltrexone—alcohol dependence	0.203	0.529	CbGbCtD
Alfentanil—CYP3A5—Disulfiram—alcohol dependence	0.0639	0.166	CbGbCtD
Alfentanil—ABCB1—Naltrexone—alcohol dependence	0.0447	0.116	CbGbCtD
Alfentanil—ABCB1—Citalopram—alcohol dependence	0.0296	0.0772	CbGbCtD
Alfentanil—CYP3A4—Disulfiram—alcohol dependence	0.0249	0.0649	CbGbCtD
Alfentanil—Dependence on opiates—Naltrexone—alcohol dependence	0.0231	0.232	CcSEcCtD
Alfentanil—CYP3A4—Citalopram—alcohol dependence	0.0177	0.0462	CbGbCtD
Alfentanil—ORM1—bile—alcohol dependence	0.00482	0.2	CbGeAlD
Alfentanil—Drug dependence—Naltrexone—alcohol dependence	0.00398	0.0401	CcSEcCtD
Alfentanil—Dermatitis atopic—Disulfiram—alcohol dependence	0.00321	0.0322	CcSEcCtD
Alfentanil—ORM1—saliva—alcohol dependence	0.00314	0.131	CbGeAlD
Alfentanil—Drug dependence—Citalopram—alcohol dependence	0.00252	0.0254	CcSEcCtD
Alfentanil—Procedural pain—Citalopram—alcohol dependence	0.00245	0.0247	CcSEcCtD
Alfentanil—Movement disorder—Citalopram—alcohol dependence	0.00232	0.0233	CcSEcCtD
Alfentanil—Muscle rigidity—Naltrexone—alcohol dependence	0.00216	0.0217	CcSEcCtD
Alfentanil—Shivering—Citalopram—alcohol dependence	0.00188	0.0189	CcSEcCtD
Alfentanil—OPRM1—nerve—alcohol dependence	0.00185	0.0771	CbGeAlD
Alfentanil—Laryngospasm—Acamprosate—alcohol dependence	0.00157	0.0157	CcSEcCtD
Alfentanil—Remifentanil—OPRK1—alcohol dependence	0.00139	0.203	CrCbGaD
Alfentanil—Muscle rigidity—Citalopram—alcohol dependence	0.00137	0.0138	CcSEcCtD
Alfentanil—Injection site pain—Naltrexone—alcohol dependence	0.00135	0.0136	CcSEcCtD
Alfentanil—Drowsiness—Disulfiram—alcohol dependence	0.00133	0.0134	CcSEcCtD
Alfentanil—Sufentanil—OPRK1—alcohol dependence	0.00124	0.181	CrCbGaD
Alfentanil—Myoclonus—Citalopram—alcohol dependence	0.00116	0.0117	CcSEcCtD
Alfentanil—Blood pressure increased—Naltrexone—alcohol dependence	0.00111	0.0111	CcSEcCtD
Alfentanil—Remifentanil—OPRD1—alcohol dependence	0.000981	0.143	CrCbGaD
Alfentanil—Euphoric mood—Naltrexone—alcohol dependence	0.00095	0.00956	CcSEcCtD
Alfentanil—Dermatitis atopic—Citalopram—alcohol dependence	0.000947	0.00952	CcSEcCtD
Alfentanil—Disorientation—Naltrexone—alcohol dependence	0.000897	0.00903	CcSEcCtD
Alfentanil—Sufentanil—OPRD1—alcohol dependence	0.000874	0.128	CrCbGaD
Alfentanil—OPRM1—brainstem—alcohol dependence	0.000796	0.0331	CbGeAlD
Alfentanil—OPRM1—forebrain—alcohol dependence	0.000768	0.0319	CbGeAlD
Alfentanil—Somnolence—Disulfiram—alcohol dependence	0.000753	0.00757	CcSEcCtD
Alfentanil—Remifentanil—OPRM1—alcohol dependence	0.00075	0.109	CrCbGaD
Alfentanil—Dyskinesia—Citalopram—alcohol dependence	0.000746	0.0075	CcSEcCtD
Alfentanil—Fatigue—Disulfiram—alcohol dependence	0.00073	0.00734	CcSEcCtD
Alfentanil—Pain—Disulfiram—alcohol dependence	0.000724	0.00728	CcSEcCtD
Alfentanil—Hiccups—Citalopram—alcohol dependence	0.000701	0.00705	CcSEcCtD
Alfentanil—Blood pressure increased—Citalopram—alcohol dependence	0.000701	0.00705	CcSEcCtD
Alfentanil—CYP3A7—endocrine gland—alcohol dependence	0.000687	0.0286	CbGeAlD
Alfentanil—Sufentanil—OPRM1—alcohol dependence	0.000669	0.0976	CrCbGaD
Alfentanil—CYP3A7—liver—alcohol dependence	0.00062	0.0258	CbGeAlD
Alfentanil—Epistaxis—Acamprosate—alcohol dependence	0.000617	0.0062	CcSEcCtD
Alfentanil—Asthenia—Disulfiram—alcohol dependence	0.000607	0.00611	CcSEcCtD
Alfentanil—Euphoric mood—Citalopram—alcohol dependence	0.000602	0.00606	CcSEcCtD
Alfentanil—Epistaxis—Naltrexone—alcohol dependence	0.000584	0.00587	CcSEcCtD
Alfentanil—Disorientation—Citalopram—alcohol dependence	0.000569	0.00572	CcSEcCtD
Alfentanil—Visual impairment—Acamprosate—alcohol dependence	0.000566	0.00569	CcSEcCtD
Alfentanil—Dizziness—Disulfiram—alcohol dependence	0.00056	0.00563	CcSEcCtD
Alfentanil—Connective tissue disorder—Naltrexone—alcohol dependence	0.000546	0.00549	CcSEcCtD
Alfentanil—Visual disturbance—Citalopram—alcohol dependence	0.000537	0.0054	CcSEcCtD
Alfentanil—Rash—Disulfiram—alcohol dependence	0.000534	0.00537	CcSEcCtD
Alfentanil—Headache—Disulfiram—alcohol dependence	0.00053	0.00533	CcSEcCtD
Alfentanil—Immune system disorder—Acamprosate—alcohol dependence	0.00053	0.00533	CcSEcCtD
Alfentanil—CYP3A7-CYP3A51P—liver—alcohol dependence	0.000527	0.0219	CbGeAlD
Alfentanil—Chills—Acamprosate—alcohol dependence	0.000527	0.0053	CcSEcCtD
Alfentanil—Eye disorder—Naltrexone—alcohol dependence	0.000519	0.00522	CcSEcCtD
Alfentanil—Cardiac disorder—Naltrexone—alcohol dependence	0.000515	0.00518	CcSEcCtD
Alfentanil—Mental disorder—Acamprosate—alcohol dependence	0.000514	0.00517	CcSEcCtD
Alfentanil—OPRM1—blood—alcohol dependence	0.000514	0.0214	CbGeAlD
Alfentanil—OPRM1—midbrain—alcohol dependence	0.000507	0.0211	CbGeAlD
Alfentanil—Angiopathy—Naltrexone—alcohol dependence	0.000504	0.00507	CcSEcCtD
Alfentanil—Immune system disorder—Naltrexone—alcohol dependence	0.000502	0.00505	CcSEcCtD
Alfentanil—ORM1—blood—alcohol dependence	0.000501	0.0208	CbGeAlD
Alfentanil—Mediastinal disorder—Naltrexone—alcohol dependence	0.000501	0.00503	CcSEcCtD
Alfentanil—Chills—Naltrexone—alcohol dependence	0.000498	0.00501	CcSEcCtD
Alfentanil—Mental disorder—Naltrexone—alcohol dependence	0.000487	0.00489	CcSEcCtD
Alfentanil—Cardiac arrest—Citalopram—alcohol dependence	0.000484	0.00486	CcSEcCtD
Alfentanil—Agitation—Acamprosate—alcohol dependence	0.00047	0.00472	CcSEcCtD
Alfentanil—Vision blurred—Naltrexone—alcohol dependence	0.000456	0.00458	CcSEcCtD
Alfentanil—Loss of consciousness—Acamprosate—alcohol dependence	0.000449	0.00452	CcSEcCtD
Alfentanil—Cough—Acamprosate—alcohol dependence	0.000446	0.00448	CcSEcCtD
Alfentanil—OPRM1—endocrine gland—alcohol dependence	0.000446	0.0185	CbGeAlD
Alfentanil—Agitation—Naltrexone—alcohol dependence	0.000444	0.00447	CcSEcCtD
Alfentanil—Convulsion—Acamprosate—alcohol dependence	0.000443	0.00445	CcSEcCtD
Alfentanil—Hypertension—Acamprosate—alcohol dependence	0.000441	0.00444	CcSEcCtD
Alfentanil—ORM1—endocrine gland—alcohol dependence	0.000435	0.0181	CbGeAlD
Alfentanil—Bronchospasm—Citalopram—alcohol dependence	0.000432	0.00435	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000432	0.00435	CcSEcCtD
Alfentanil—Loss of consciousness—Naltrexone—alcohol dependence	0.000425	0.00427	CcSEcCtD
Alfentanil—OPRM1—testis—alcohol dependence	0.000425	0.0177	CbGeAlD
Alfentanil—Fentanyl—OPRK1—alcohol dependence	0.000422	0.0616	CrCbGaD
Alfentanil—Cough—Naltrexone—alcohol dependence	0.000422	0.00424	CcSEcCtD
Alfentanil—Confusional state—Acamprosate—alcohol dependence	0.000421	0.00423	CcSEcCtD
Alfentanil—Convulsion—Naltrexone—alcohol dependence	0.000419	0.00421	CcSEcCtD
Alfentanil—Hypertension—Naltrexone—alcohol dependence	0.000417	0.0042	CcSEcCtD
Alfentanil—Anaphylactic shock—Acamprosate—alcohol dependence	0.000417	0.00419	CcSEcCtD
Alfentanil—OPRM1—nervous system—alcohol dependence	0.000417	0.0173	CbGeAlD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000409	0.00411	CcSEcCtD
Alfentanil—ORM1—nervous system—alcohol dependence	0.000407	0.0169	CbGeAlD
Alfentanil—Tachycardia—Acamprosate—alcohol dependence	0.000407	0.00409	CcSEcCtD
Alfentanil—Skin disorder—Acamprosate—alcohol dependence	0.000405	0.00407	CcSEcCtD
Alfentanil—Hyperhidrosis—Acamprosate—alcohol dependence	0.000403	0.00405	CcSEcCtD
Alfentanil—OPRM1—central nervous system—alcohol dependence	0.000402	0.0167	CbGeAlD
Alfentanil—Confusional state—Naltrexone—alcohol dependence	0.000398	0.004	CcSEcCtD
Alfentanil—Anaphylactic shock—Naltrexone—alcohol dependence	0.000395	0.00397	CcSEcCtD
Alfentanil—ORM1—liver—alcohol dependence	0.000392	0.0163	CbGeAlD
Alfentanil—ORM1—central nervous system—alcohol dependence	0.000392	0.0163	CbGeAlD
Alfentanil—Hypotension—Acamprosate—alcohol dependence	0.00039	0.00392	CcSEcCtD
Alfentanil—Nervous system disorder—Naltrexone—alcohol dependence	0.000387	0.00389	CcSEcCtD
Alfentanil—Tachycardia—Naltrexone—alcohol dependence	0.000385	0.00387	CcSEcCtD
Alfentanil—Skin disorder—Naltrexone—alcohol dependence	0.000383	0.00385	CcSEcCtD
Alfentanil—Hyperhidrosis—Naltrexone—alcohol dependence	0.000381	0.00384	CcSEcCtD
Alfentanil—Somnolence—Acamprosate—alcohol dependence	0.000371	0.00373	CcSEcCtD
Alfentanil—Epistaxis—Citalopram—alcohol dependence	0.00037	0.00372	CcSEcCtD
Alfentanil—ALB—testis—alcohol dependence	0.000364	0.0151	CbGeAlD
Alfentanil—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00036	0.00362	CcSEcCtD
Alfentanil—Bradycardia—Citalopram—alcohol dependence	0.000358	0.0036	CcSEcCtD
Alfentanil—Pain—Acamprosate—alcohol dependence	0.000357	0.00359	CcSEcCtD
Alfentanil—Somnolence—Naltrexone—alcohol dependence	0.000351	0.00353	CcSEcCtD
Alfentanil—Connective tissue disorder—Citalopram—alcohol dependence	0.000346	0.00348	CcSEcCtD
Alfentanil—ALB—liver—alcohol dependence	0.000344	0.0143	CbGeAlD
Alfentanil—Feeling abnormal—Acamprosate—alcohol dependence	0.000344	0.00346	CcSEcCtD
Alfentanil—CYP3A5—pancreas—alcohol dependence	0.000343	0.0142	CbGeAlD
Alfentanil—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000341	0.00343	CcSEcCtD
Alfentanil—Fatigue—Naltrexone—alcohol dependence	0.00034	0.00342	CcSEcCtD
Alfentanil—Visual impairment—Citalopram—alcohol dependence	0.000339	0.00341	CcSEcCtD
Alfentanil—Pain—Naltrexone—alcohol dependence	0.000337	0.00339	CcSEcCtD
Alfentanil—Urticaria—Acamprosate—alcohol dependence	0.000331	0.00333	CcSEcCtD
Alfentanil—Body temperature increased—Acamprosate—alcohol dependence	0.00033	0.00332	CcSEcCtD
Alfentanil—Eye disorder—Citalopram—alcohol dependence	0.000329	0.00331	CcSEcCtD
Alfentanil—Cardiac disorder—Citalopram—alcohol dependence	0.000327	0.00328	CcSEcCtD
Alfentanil—Feeling abnormal—Naltrexone—alcohol dependence	0.000325	0.00327	CcSEcCtD
Alfentanil—Angiopathy—Citalopram—alcohol dependence	0.000319	0.00321	CcSEcCtD
Alfentanil—OPRM1—brain—alcohol dependence	0.000319	0.0132	CbGeAlD
Alfentanil—Immune system disorder—Citalopram—alcohol dependence	0.000318	0.0032	CcSEcCtD
Alfentanil—Mediastinal disorder—Citalopram—alcohol dependence	0.000317	0.00319	CcSEcCtD
Alfentanil—Chills—Citalopram—alcohol dependence	0.000316	0.00318	CcSEcCtD
Alfentanil—Arrhythmia—Citalopram—alcohol dependence	0.000314	0.00316	CcSEcCtD
Alfentanil—Urticaria—Naltrexone—alcohol dependence	0.000313	0.00315	CcSEcCtD
Alfentanil—Body temperature increased—Naltrexone—alcohol dependence	0.000312	0.00314	CcSEcCtD
Alfentanil—Mental disorder—Citalopram—alcohol dependence	0.000308	0.0031	CcSEcCtD
Alfentanil—Hypersensitivity—Acamprosate—alcohol dependence	0.000307	0.00309	CcSEcCtD
Alfentanil—Erythema—Citalopram—alcohol dependence	0.000306	0.00308	CcSEcCtD
Alfentanil—Asthenia—Acamprosate—alcohol dependence	0.000299	0.00301	CcSEcCtD
Alfentanil—Fentanyl—OPRD1—alcohol dependence	0.000297	0.0434	CrCbGaD
Alfentanil—Pruritus—Acamprosate—alcohol dependence	0.000295	0.00297	CcSEcCtD
Alfentanil—CYP3A5—digestive system—alcohol dependence	0.000293	0.0122	CbGeAlD
Alfentanil—Hypersensitivity—Naltrexone—alcohol dependence	0.000291	0.00292	CcSEcCtD
Alfentanil—Vision blurred—Citalopram—alcohol dependence	0.000289	0.0029	CcSEcCtD
Alfentanil—Asthenia—Naltrexone—alcohol dependence	0.000283	0.00285	CcSEcCtD
Alfentanil—Agitation—Citalopram—alcohol dependence	0.000282	0.00283	CcSEcCtD
Alfentanil—Pruritus—Naltrexone—alcohol dependence	0.000279	0.00281	CcSEcCtD
Alfentanil—CYP3A5—blood—alcohol dependence	0.000279	0.0116	CbGeAlD
Alfentanil—Dizziness—Acamprosate—alcohol dependence	0.000276	0.00277	CcSEcCtD
Alfentanil—ALB—brain—alcohol dependence	0.000273	0.0113	CbGeAlD
Alfentanil—Loss of consciousness—Citalopram—alcohol dependence	0.000269	0.00271	CcSEcCtD
Alfentanil—Cough—Citalopram—alcohol dependence	0.000267	0.00269	CcSEcCtD
Alfentanil—Convulsion—Citalopram—alcohol dependence	0.000265	0.00267	CcSEcCtD
Alfentanil—Vomiting—Acamprosate—alcohol dependence	0.000265	0.00267	CcSEcCtD
Alfentanil—Hypertension—Citalopram—alcohol dependence	0.000264	0.00266	CcSEcCtD
Alfentanil—Rash—Acamprosate—alcohol dependence	0.000263	0.00264	CcSEcCtD
Alfentanil—Dermatitis—Acamprosate—alcohol dependence	0.000263	0.00264	CcSEcCtD
Alfentanil—Headache—Acamprosate—alcohol dependence	0.000261	0.00263	CcSEcCtD
Alfentanil—Dizziness—Naltrexone—alcohol dependence	0.000261	0.00262	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000259	0.0026	CcSEcCtD
Alfentanil—Confusional state—Citalopram—alcohol dependence	0.000252	0.00254	CcSEcCtD
Alfentanil—Vomiting—Naltrexone—alcohol dependence	0.000251	0.00252	CcSEcCtD
Alfentanil—Anaphylactic shock—Citalopram—alcohol dependence	0.00025	0.00251	CcSEcCtD
Alfentanil—Rash—Naltrexone—alcohol dependence	0.000249	0.0025	CcSEcCtD
Alfentanil—Dermatitis—Naltrexone—alcohol dependence	0.000249	0.0025	CcSEcCtD
Alfentanil—Nausea—Acamprosate—alcohol dependence	0.000248	0.00249	CcSEcCtD
Alfentanil—Headache—Naltrexone—alcohol dependence	0.000247	0.00249	CcSEcCtD
Alfentanil—Nervous system disorder—Citalopram—alcohol dependence	0.000245	0.00247	CcSEcCtD
Alfentanil—Tachycardia—Citalopram—alcohol dependence	0.000244	0.00245	CcSEcCtD
Alfentanil—Skin disorder—Citalopram—alcohol dependence	0.000243	0.00244	CcSEcCtD
Alfentanil—CYP3A5—endocrine gland—alcohol dependence	0.000242	0.0101	CbGeAlD
Alfentanil—Hyperhidrosis—Citalopram—alcohol dependence	0.000242	0.00243	CcSEcCtD
Alfentanil—Nausea—Naltrexone—alcohol dependence	0.000234	0.00236	CcSEcCtD
Alfentanil—Hypotension—Citalopram—alcohol dependence	0.000234	0.00235	CcSEcCtD
Alfentanil—Fentanyl—OPRM1—alcohol dependence	0.000228	0.0332	CrCbGaD
Alfentanil—Somnolence—Citalopram—alcohol dependence	0.000222	0.00224	CcSEcCtD
Alfentanil—ABCB1—forebrain—alcohol dependence	0.000222	0.00921	CbGeAlD
Alfentanil—CYP3A4—digestive system—alcohol dependence	0.00022	0.00913	CbGeAlD
Alfentanil—CYP3A5—liver—alcohol dependence	0.000218	0.00906	CbGeAlD
Alfentanil—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000216	0.00217	CcSEcCtD
Alfentanil—Fatigue—Citalopram—alcohol dependence	0.000216	0.00217	CcSEcCtD
Alfentanil—Pain—Citalopram—alcohol dependence	0.000214	0.00215	CcSEcCtD
Alfentanil—CYP3A4—blood—alcohol dependence	0.000209	0.0087	CbGeAlD
Alfentanil—Feeling abnormal—Citalopram—alcohol dependence	0.000206	0.00207	CcSEcCtD
Alfentanil—ABCB1—adrenal cortex—alcohol dependence	0.000205	0.00853	CbGeAlD
Alfentanil—Urticaria—Citalopram—alcohol dependence	0.000199	0.002	CcSEcCtD
Alfentanil—Body temperature increased—Citalopram—alcohol dependence	0.000198	0.00199	CcSEcCtD
Alfentanil—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000193	0.00515	CbGpPWpGaD
Alfentanil—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000192	0.00512	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—ADH1B—alcohol dependence	0.00019	0.00505	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—PDYN—alcohol dependence	0.00019	0.00505	CbGpPWpGaD
Alfentanil—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000189	0.00504	CbGpPWpGaD
Alfentanil—ABCB1—cardiovascular system—alcohol dependence	0.000187	0.00779	CbGeAlD
Alfentanil—Hypersensitivity—Citalopram—alcohol dependence	0.000184	0.00185	CcSEcCtD
Alfentanil—CYP3A5—Biological oxidations—ADH4—alcohol dependence	0.000184	0.0049	CbGpPWpGaD
Alfentanil—ABCB1—pancreas—alcohol dependence	0.000182	0.00757	CbGeAlD
Alfentanil—CYP3A5—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000182	0.00485	CbGpPWpGaD
Alfentanil—CYP3A4—endocrine gland—alcohol dependence	0.000182	0.00754	CbGeAlD
Alfentanil—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—alcohol dependence	0.00018	0.00478	CbGpPWpGaD
Alfentanil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00018	0.00478	CbGpPWpGaD
Alfentanil—Asthenia—Citalopram—alcohol dependence	0.000179	0.0018	CcSEcCtD
Alfentanil—CYP3A5—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000177	0.00472	CbGpPWpGaD
Alfentanil—Pruritus—Citalopram—alcohol dependence	0.000177	0.00178	CcSEcCtD
Alfentanil—ABCB1—gonad—alcohol dependence	0.00017	0.00707	CbGeAlD
Alfentanil—CYP3A4—nervous system—alcohol dependence	0.00017	0.00706	CbGeAlD
Alfentanil—OPRM1—G alpha (i) signalling events—OPRD1—alcohol dependence	0.000167	0.00444	CbGpPWpGaD
Alfentanil—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000166	0.00441	CbGpPWpGaD
Alfentanil—Dizziness—Citalopram—alcohol dependence	0.000165	0.00166	CcSEcCtD
Alfentanil—CYP3A4—liver—alcohol dependence	0.000164	0.0068	CbGeAlD
Alfentanil—CYP3A4—central nervous system—alcohol dependence	0.000164	0.0068	CbGeAlD
Alfentanil—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000161	0.00429	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—PDYN—alcohol dependence	0.00016	0.00426	CbGpPWpGaD
Alfentanil—Vomiting—Citalopram—alcohol dependence	0.000159	0.0016	CcSEcCtD
Alfentanil—Rash—Citalopram—alcohol dependence	0.000158	0.00159	CcSEcCtD
Alfentanil—Dermatitis—Citalopram—alcohol dependence	0.000157	0.00158	CcSEcCtD
Alfentanil—CYP3A7—Biological oxidations—MAOB—alcohol dependence	0.000157	0.00419	CbGpPWpGaD
Alfentanil—Headache—Citalopram—alcohol dependence	0.000157	0.00158	CcSEcCtD
Alfentanil—CYP3A5—Biological oxidations—ADH7—alcohol dependence	0.000157	0.00417	CbGpPWpGaD
Alfentanil—ABCB1—digestive system—alcohol dependence	0.000156	0.00646	CbGeAlD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.000155	0.00412	CbGpPWpGaD
Alfentanil—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000152	0.00404	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—OPRK1—alcohol dependence	0.00015	0.004	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—GGT2—alcohol dependence	0.00015	0.00399	CbGpPWpGaD
Alfentanil—Nausea—Citalopram—alcohol dependence	0.000149	0.00149	CcSEcCtD
Alfentanil—ABCB1—blood—alcohol dependence	0.000148	0.00616	CbGeAlD
Alfentanil—ABCB1—midbrain—alcohol dependence	0.000146	0.00608	CbGeAlD
Alfentanil—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000146	0.00387	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—NPY—alcohol dependence	0.00014	0.00373	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—CHRM2—alcohol dependence	0.00014	0.00372	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—ADH1B—alcohol dependence	0.000137	0.00365	CbGpPWpGaD
Alfentanil—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000137	0.00365	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—ALDH2—alcohol dependence	0.000134	0.00356	CbGpPWpGaD
Alfentanil—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000133	0.00354	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.000133	0.00353	CbGpPWpGaD
Alfentanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000131	0.0035	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.00013	0.00345	CbGpPWpGaD
Alfentanil—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000129	0.00344	CbGpPWpGaD
Alfentanil—ABCB1—endocrine gland—alcohol dependence	0.000129	0.00534	CbGeAlD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.000127	0.00338	CbGpPWpGaD
Alfentanil—ABCB1—testis—alcohol dependence	0.000123	0.00509	CbGeAlD
Alfentanil—OPRM1—Opioid Signalling—POMC—alcohol dependence	0.000122	0.00324	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000121	0.00323	CbGpPWpGaD
Alfentanil—ABCB1—nervous system—alcohol dependence	0.00012	0.005	CbGeAlD
Alfentanil—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00012	0.0032	CbGpPWpGaD
Alfentanil—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00012	0.00319	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—NPY—alcohol dependence	0.000118	0.00314	CbGpPWpGaD
Alfentanil—ABCB1—liver—alcohol dependence	0.000116	0.00482	CbGeAlD
Alfentanil—ABCB1—central nervous system—alcohol dependence	0.000116	0.00481	CbGeAlD
Alfentanil—OPRM1—G alpha (i) signalling events—HTR1B—alcohol dependence	0.000114	0.00303	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—MAOB—alcohol dependence	0.000114	0.00303	CbGpPWpGaD
Alfentanil—ABCB1—cerebellum—alcohol dependence	0.000113	0.0047	CbGeAlD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.000111	0.00296	CbGpPWpGaD
Alfentanil—CYP3A7—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000108	0.00287	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—CYP2E1—alcohol dependence	0.000107	0.00285	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000106	0.00281	CbGpPWpGaD
Alfentanil—CYP3A7—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000105	0.00281	CbGpPWpGaD
Alfentanil—ALB—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000104	0.00278	CbGpPWpGaD
Alfentanil—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000103	0.00275	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—OPRD1—alcohol dependence	0.000101	0.00269	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000101	0.00268	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—DRD4—alcohol dependence	9.96e-05	0.00265	CbGpPWpGaD
Alfentanil—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	9.95e-05	0.00265	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—GGT1—alcohol dependence	9.82e-05	0.00261	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—PDYN—alcohol dependence	9.68e-05	0.00258	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—ALDH2—alcohol dependence	9.67e-05	0.00257	CbGpPWpGaD
Alfentanil—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	9.62e-05	0.00256	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—CNR1—alcohol dependence	9.51e-05	0.00253	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	9.39e-05	0.0025	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—DRD2—alcohol dependence	9.28e-05	0.00247	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—AVP—alcohol dependence	9.26e-05	0.00246	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	9.24e-05	0.00246	CbGpPWpGaD
Alfentanil—ABCB1—brain—alcohol dependence	9.19e-05	0.00382	CbGeAlD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	9.06e-05	0.00241	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—CRHR1—alcohol dependence	9e-05	0.0024	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	8.82e-05	0.00235	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—MAOA—alcohol dependence	8.8e-05	0.00234	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	8.61e-05	0.00229	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	8.61e-05	0.00229	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—ADH4—alcohol dependence	8.56e-05	0.00228	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—OPRK1—alcohol dependence	8.49e-05	0.00226	CbGpPWpGaD
Alfentanil—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	8.46e-05	0.00225	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—CHRM2—alcohol dependence	8.46e-05	0.00225	CbGpPWpGaD
Alfentanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	8.35e-05	0.00222	CbGpPWpGaD
Alfentanil—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	8.24e-05	0.00219	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	7.92e-05	0.00211	CbGpPWpGaD
Alfentanil—CYP3A5—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	7.8e-05	0.00208	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—CYP2E1—alcohol dependence	7.73e-05	0.00206	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—OPRK1—alcohol dependence	7.71e-05	0.00205	CbGpPWpGaD
Alfentanil—CYP3A5—Metapathway biotransformation—CYP2E1—alcohol dependence	7.62e-05	0.00203	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	7.56e-05	0.00201	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	7.38e-05	0.00196	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	7.38e-05	0.00196	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—ADH7—alcohol dependence	7.28e-05	0.00194	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—NPY—alcohol dependence	7.15e-05	0.0019	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—GGT1—alcohol dependence	7.1e-05	0.00189	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—GGT2—alcohol dependence	6.98e-05	0.00186	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—CRH—alcohol dependence	6.9e-05	0.00184	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—HTR1B—alcohol dependence	6.9e-05	0.00184	CbGpPWpGaD
Alfentanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	6.77e-05	0.0018	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	6.38e-05	0.0017	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—MAOA—alcohol dependence	6.36e-05	0.00169	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	6.21e-05	0.00165	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ADH6—alcohol dependence	6.18e-05	0.00165	CbGpPWpGaD
Alfentanil—OPRM1—Peptide ligand-binding receptors—POMC—alcohol dependence	6.15e-05	0.00164	CbGpPWpGaD
Alfentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	6.03e-05	0.00161	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—DRD4—alcohol dependence	6.03e-05	0.00161	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—CNR1—alcohol dependence	5.76e-05	0.00153	CbGpPWpGaD
Alfentanil—CYP3A7—Biological oxidations—POMC—alcohol dependence	5.73e-05	0.00152	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—OPRD1—alcohol dependence	5.71e-05	0.00152	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—DRD2—alcohol dependence	5.62e-05	0.0015	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—HTR7—alcohol dependence	5.62e-05	0.0015	CbGpPWpGaD
Alfentanil—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	5.57e-05	0.00148	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PDYN—alcohol dependence	5.47e-05	0.00146	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—MAOB—alcohol dependence	5.29e-05	0.00141	CbGpPWpGaD
Alfentanil—OPRM1—G alpha (i) signalling events—POMC—alcohol dependence	5.19e-05	0.00138	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—OPRD1—alcohol dependence	5.18e-05	0.00138	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	5.17e-05	0.00138	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ADH1A—alcohol dependence	5.12e-05	0.00136	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CRHR1—alcohol dependence	5.09e-05	0.00135	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PDYN—alcohol dependence	4.97e-05	0.00132	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—GABRB1—alcohol dependence	4.92e-05	0.00131	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CHRM2—alcohol dependence	4.78e-05	0.00127	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—AVP—alcohol dependence	4.73e-05	0.00126	CbGpPWpGaD
Alfentanil—ALB—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	4.66e-05	0.00124	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CRHR1—alcohol dependence	4.62e-05	0.00123	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—OPRK1—alcohol dependence	4.55e-05	0.00121	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	4.5e-05	0.0012	CbGpPWpGaD
Alfentanil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	4.47e-05	0.00119	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ADH6—alcohol dependence	4.47e-05	0.00119	CbGpPWpGaD
Alfentanil—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	4.46e-05	0.00119	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ADH4—alcohol dependence	4.35e-05	0.00116	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CHRM2—alcohol dependence	4.34e-05	0.00116	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	4.31e-05	0.00115	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—GABRA2—alcohol dependence	4.18e-05	0.00111	CbGpPWpGaD
Alfentanil—CYP3A5—Biological oxidations—POMC—alcohol dependence	4.14e-05	0.0011	CbGpPWpGaD
Alfentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	4.13e-05	0.0011	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—NPY—alcohol dependence	4.04e-05	0.00108	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—HTR2A—alcohol dependence	3.93e-05	0.00105	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—HTR1B—alcohol dependence	3.9e-05	0.00104	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CRH—alcohol dependence	3.9e-05	0.00104	CbGpPWpGaD
Alfentanil—ALB—SLC-mediated transmembrane transport—AVP—alcohol dependence	3.86e-05	0.00103	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADH6—alcohol dependence	3.85e-05	0.00102	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ADH7—alcohol dependence	3.7e-05	0.000986	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ADH1A—alcohol dependence	3.7e-05	0.000986	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—NPY—alcohol dependence	3.67e-05	0.000977	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	3.67e-05	0.000976	CbGpPWpGaD
Alfentanil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	3.62e-05	0.000965	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	3.59e-05	0.000957	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GGT2—alcohol dependence	3.55e-05	0.000945	CbGpPWpGaD
Alfentanil—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	3.54e-05	0.000944	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HTR1B—alcohol dependence	3.54e-05	0.000942	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CRH—alcohol dependence	3.54e-05	0.000942	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—DRD4—alcohol dependence	3.41e-05	0.000907	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADH6—alcohol dependence	3.37e-05	0.000898	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—GGT1—alcohol dependence	3.3e-05	0.000878	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CNR1—alcohol dependence	3.25e-05	0.000866	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ADH1B—alcohol dependence	3.25e-05	0.000864	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADH1A—alcohol dependence	3.19e-05	0.000849	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—DRD2—alcohol dependence	3.17e-05	0.000845	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—HTR7—alcohol dependence	3.17e-05	0.000845	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ADH4—alcohol dependence	3.15e-05	0.000838	CbGpPWpGaD
Alfentanil—OPRM1—GPCR ligand binding—POMC—alcohol dependence	3.14e-05	0.000836	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—DRD4—alcohol dependence	3.09e-05	0.000824	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—OPRD1—alcohol dependence	3.06e-05	0.000815	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—MAOA—alcohol dependence	2.96e-05	0.000787	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CNR1—alcohol dependence	2.95e-05	0.000786	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PDYN—alcohol dependence	2.93e-05	0.000781	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—DRD2—alcohol dependence	2.88e-05	0.000767	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HTR7—alcohol dependence	2.88e-05	0.000767	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADH1A—alcohol dependence	2.79e-05	0.000744	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CRHR1—alcohol dependence	2.73e-05	0.000726	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—WASF2—alcohol dependence	2.73e-05	0.000726	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADH4—alcohol dependence	2.71e-05	0.000722	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MAOB—alcohol dependence	2.69e-05	0.000716	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ADH7—alcohol dependence	2.68e-05	0.000713	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AVP—alcohol dependence	2.67e-05	0.000711	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—WASF1—alcohol dependence	2.62e-05	0.000696	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GGT2—alcohol dependence	2.57e-05	0.000683	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CHRM2—alcohol dependence	2.57e-05	0.000683	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AVP—alcohol dependence	2.43e-05	0.000646	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADH4—alcohol dependence	2.38e-05	0.000632	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.37e-05	0.000631	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.35e-05	0.000625	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ADH1B—alcohol dependence	2.35e-05	0.000625	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADH7—alcohol dependence	2.31e-05	0.000614	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALDH2—alcohol dependence	2.29e-05	0.000609	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—HTR2A—alcohol dependence	2.22e-05	0.000592	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GGT2—alcohol dependence	2.21e-05	0.000588	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NPY—alcohol dependence	2.17e-05	0.000577	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HTR1B—alcohol dependence	2.09e-05	0.000557	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CRH—alcohol dependence	2.09e-05	0.000557	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADH6—alcohol dependence	2.08e-05	0.000553	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.08e-05	0.000553	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ADH1B—alcohol dependence	2.02e-05	0.000538	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADH7—alcohol dependence	2.02e-05	0.000538	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HTR2A—alcohol dependence	2.02e-05	0.000537	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—AVP—alcohol dependence	1.96e-05	0.000522	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GOT2—alcohol dependence	1.95e-05	0.000518	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MAOB—alcohol dependence	1.94e-05	0.000518	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GGT2—alcohol dependence	1.94e-05	0.000515	CbGpPWpGaD
Alfentanil—CYP3A4—Biological oxidations—POMC—alcohol dependence	1.93e-05	0.000512	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	1.91e-05	0.000507	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP2E1—alcohol dependence	1.83e-05	0.000487	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—DRD4—alcohol dependence	1.83e-05	0.000487	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—POMC—alcohol dependence	1.78e-05	0.000473	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ADH1B—alcohol dependence	1.77e-05	0.000471	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CNR1—alcohol dependence	1.75e-05	0.000465	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.72e-05	0.000458	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	1.72e-05	0.000457	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—DRD2—alcohol dependence	1.7e-05	0.000453	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HTR7—alcohol dependence	1.7e-05	0.000453	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GGT1—alcohol dependence	1.68e-05	0.000447	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GOT1—alcohol dependence	1.68e-05	0.000447	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MAOB—alcohol dependence	1.67e-05	0.000446	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALDH2—alcohol dependence	1.65e-05	0.00044	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—POMC—alcohol dependence	1.61e-05	0.000429	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MAOA—alcohol dependence	1.5e-05	0.000401	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MAOB—alcohol dependence	1.47e-05	0.000391	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADH4—alcohol dependence	1.46e-05	0.00039	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AVP—alcohol dependence	1.43e-05	0.000382	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALDH2—alcohol dependence	1.42e-05	0.000379	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GOT2—alcohol dependence	1.41e-05	0.000374	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.37e-05	0.000365	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2E1—alcohol dependence	1.32e-05	0.000352	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALDH2—alcohol dependence	1.25e-05	0.000332	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADH7—alcohol dependence	1.24e-05	0.000331	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GGT1—alcohol dependence	1.21e-05	0.000323	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GOT1—alcohol dependence	1.21e-05	0.000323	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GOT2—alcohol dependence	1.21e-05	0.000322	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GGT2—alcohol dependence	1.19e-05	0.000318	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HTR2A—alcohol dependence	1.19e-05	0.000317	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2E1—alcohol dependence	1.14e-05	0.000303	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.09e-05	0.00029	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MAOA—alcohol dependence	1.09e-05	0.00029	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GOT2—alcohol dependence	1.06e-05	0.000282	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GOT1—alcohol dependence	1.05e-05	0.000278	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GGT1—alcohol dependence	1.05e-05	0.000278	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—EP300—alcohol dependence	9.98e-06	0.000266	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2E1—alcohol dependence	9.98e-06	0.000266	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—POMC—alcohol dependence	9.8e-06	0.000261	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—POMC—alcohol dependence	9.52e-06	0.000254	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MAOA—alcohol dependence	9.37e-06	0.000249	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GOT1—alcohol dependence	9.16e-06	0.000244	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GGT1—alcohol dependence	9.16e-06	0.000244	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	9.08e-06	0.000242	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MAOB—alcohol dependence	9.04e-06	0.000241	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MAOA—alcohol dependence	8.21e-06	0.000218	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALDH2—alcohol dependence	7.69e-06	0.000205	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—POMC—alcohol dependence	7.08e-06	0.000189	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GOT2—alcohol dependence	6.54e-06	0.000174	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—EP300—alcohol dependence	6.5e-06	0.000173	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EP300—alcohol dependence	6.32e-06	0.000168	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2E1—alcohol dependence	6.15e-06	0.000164	CbGpPWpGaD
Alfentanil—ALB—Metabolism—POMC—alcohol dependence	6.1e-06	0.000162	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GGT1—alcohol dependence	5.64e-06	0.00015	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GOT1—alcohol dependence	5.64e-06	0.00015	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—POMC—alcohol dependence	5.34e-06	0.000142	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MAOA—alcohol dependence	5.06e-06	0.000135	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—EP300—alcohol dependence	4.7e-06	0.000125	CbGpPWpGaD
Alfentanil—ALB—Metabolism—EP300—alcohol dependence	4.05e-06	0.000108	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—EP300—alcohol dependence	3.54e-06	9.44e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—POMC—alcohol dependence	3.29e-06	8.76e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—EP300—alcohol dependence	2.18e-06	5.81e-05	CbGpPWpGaD
